Biotech Startups
10,071 companies tagged Biotech, with their investors and founders.
0 investors
RMS develops stem cell therapies to regenerate insulin-producing pancreatic beta cells as a potential cure for Type 1 and Type 2 diabetes. The company uses induced pluripotent stem cell (iPSC) technology to create scalable, non-embryonic solutions that aim to restore natural insulin function.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Renata Medical develops and commercializes medical devices for unmet pediatric needs, with a focus on transcatheter implants and delivery systems such as stents for treating congenital heart defects in newborns and children. Its products include the FDA-approved Minima stent used to treat conditions like coarctation of the aorta.
0 investors
RenBio develops DNA-based therapeutic technology that uses intramuscular injection of therapeutic-encoding "bioblueprints" so a patient's own muscle cells produce antibodies and therapeutic proteins to prevent and treat diseases, including infectious diseases. The company works in the antibody and therapeutic protein field, aiming to overcome obstacles in delivery, durability, and cost.
0 investors
Renerva develops implantable medical devices to treat peripheral nerve injuries. The company was founded from academic research at the University of Pittsburgh and Cornell University.
0 investors
0 investors
0 investors
Renovo Concepts develops Mechanical Tissue Resuscitation (MTR), a therapy that applies controlled sub-atmospheric pressure to remove excess fluid from damaged brain, heart, and spinal tissue in order to reduce secondary injury. Its first clinical indication is traumatic brain injury, and the company is conducting first-in-human clinical trials.
0 investors
Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.
0 investors
Reprise Biomedical develops and commercializes biologic medical devices using a proprietary perfusion decellularization process for surgical applications. The company serves physicians and healthcare providers delivering medical devices for a range of surgical procedures.
0 investors
resbiotic develops physician-formulated prebiotic, probiotic, and postbiotic supplements alongside microbiome testing to address gut health and chronic conditions. The consumer wellness brand bases its products on clinical trials and scientific research, offering personalized restoration recommendations.
0 investors
0 investors